UB Paderborn / Katalog / Suche / in CDI

SSR180711, a Novel Selective α7 Nicotinic Receptor Partial Agonist: (1) Binding and Functional Profile

Neuropsychopharmacology (New York, N.Y.), 2006-10, Vol.32 (1), p.1-16

2006

Link zum Volltext

Verfügbarkeit prüfen

Haloperidol-induced catalepsy is absent in dopamine D2, but maintained in dopamine D3 receptor knock-out mice

European journal of pharmacology, , Vol.391 (1-2), p.63-73

Link zum Volltext

Verfügbarkeit prüfen

Haloperidol-induced catalepsy is absent in dopamine D 2, but maintained in dopamine D 3 receptor knock-out mice

European journal of pharmacology, 2000-03, Vol.391 (1), p.63-73

2000

Link zum Volltext

Verfügbarkeit prüfen

Amisulpride: from animal pharmacology to therapeutic action

International clinical psychopharmacology, 1997-05, Vol.12 Suppl 2 (Supplement 2), p.S29-S36

1997

Link zum Volltext

Verfügbarkeit prüfen

SSR181507, A Dopamine D Receptor Antagonist and 5-HT Receptor Agonist. I: Neurochemical and Electrophysiological Profile

Neuropsychopharmacology, 2003-12, Vol.28 (12), p.2064-2076

2003

Link zum Volltext

Verfügbarkeit prüfen

SSR181507, a dopamine D2 receptor antagonist and 5-HT1A receptor agonist. I: Neurochemical and electrophysiological profile

Neuropsychopharmacology (New York, N.Y.), 2003-12, Vol.28 (12), p.2064-2076

2003

Link zum Volltext

Verfügbarkeit prüfen

Complex allosteric modulation of the binding of the NMDA receptor antagonist [ 3H]CGP39653

European journal of pharmacology, 1994, Vol.266 (1), p.103-106

1994

Link zum Volltext

Verfügbarkeit prüfen

Involvement of the D-2 dopamine receptor in the neuroleptic-induced decrease in nigral substance P

European journal of pharmacology, 1984-10, Vol.105 (1), p.175-177

1984

Link zum Volltext

Verfügbarkeit prüfen

Selective antagonists of dopamine receptor subtypes differentially affect substance P levels in the striatum and substantia nigra

Brain research, 1987-09, Vol.421 (1), p.387-390

1987

Link zum Volltext

Verfügbarkeit prüfen

Progabide reverses the nigral substance P reduction induced by chronic impairment of dopaminergic transmission

European journal of pharmacology, 1985-06, Vol.112 (2), p.253-255

1985

Link zum Volltext

Verfügbarkeit prüfen

Degradation of substance P by membrane peptidases in the rat substantia nigra: Effect of selective inhibitors

Neuroscience letters, 1988-01, Vol.84 (1), p.91-96

1988

Link zum Volltext

Verfügbarkeit prüfen

Influence of lithium on biochemical manifestations of striatal dopamine target cell supersensitivity induced by prolonged haloperidol treatment

European journal of pharmacology, 1983-09, Vol.93 (1), p.55-62

1983

Link zum Volltext

Verfügbarkeit prüfen

Solid‐Phase Radioimmunoassay for Substance P

Journal of neurochemistry, 1983-03, Vol.40 (3), p.783-789

1983

Link zum Volltext

Verfügbarkeit prüfen

Met909 Plays a Key Role in the Activation of the Progesterone Receptor and Also in the High Potency of 13-Ethyl Progestins

Molecular pharmacology, 2009-06, Vol.75 (6), p.1317-1324

2009

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

SSR180711, a Novel Selective α7 Nicotinic Receptor Partial Agonist: (1) Binding and Functional Profile

SSR180711, a novel selective alpha 7 nicotinic receptor partial agonist: (I) binding and functional profile

Haloperidol-induced catalepsy is absent in dopamine D2, but maintained in dopamine D3 receptor knock-out mice

Haloperidol-induced catalepsy is absent in dopamine D 2, but maintained in dopamine D 3 receptor knock-out mice

Amisulpride: from animal pharmacology to therapeutic action

SSRI80711, a novel selective α7 nicotinic receptor partial agonist: (I) binding and functional profile

SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (1) binding and functional profile

SSR181507, A Dopamine D Receptor Antagonist and 5-HT Receptor Agonist. I: Neurochemical and Electrophysiological Profile

SSR181507, a dopamine D2 receptor antagonist and 5-HT1A receptor agonist. I: Neurochemical and electrophysiological profile

Complex allosteric modulation of the binding of the NMDA receptor antagonist [ 3H]CGP39653

Involvement of the D-2 dopamine receptor in the neuroleptic-induced decrease in nigral substance P

Selective antagonists of dopamine receptor subtypes differentially affect substance P levels in the striatum and substantia nigra

Progabide reverses the nigral substance P reduction induced by chronic impairment of dopaminergic transmission

Degradation of substance P by membrane peptidases in the rat substantia nigra: Effect of selective inhibitors

Influence of lithium on biochemical manifestations of striatal dopamine target cell supersensitivity induced by prolonged haloperidol treatment

Solid‐Phase Radioimmunoassay for Substance P

Met909 Plays a Key Role in the Activation of the Progesterone Receptor and Also in the High Potency of 13-Ethyl Progestins

Suchergebnisse filtern